{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:24:30Z","timestamp":1775024670888,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To analyze the clinical characteristics and cerebrospinal fluid (CSF) biochemical indexes, tumor markers (TM) and cytomorphological indexes of patients with meningeal carcinomatosis (MC), and to explore the clinical application value of the above indexes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospectively included 209 patients with MC in 2021\u20132023 into the study and collected their clinical information and laboratory data, compared the differences in indicators and analyzed the cytomorphological features and dynamic changes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>(i) The primary foci of MC patients were mostly lung cancer (86.6%), and the clinical manifestations did not change according to the tumor of the primary foci. The main manifestations were headache (65.55%) and meningeal enhancement (67.20%); (ii)Most MC patients (96.17%) had abnormal CSF biochemical indices, with some variations among primary foci; (iii) CYFRA21\u20131 level in CSF of MC patients was significantly higher than that in serum (P&amp;lt;0.05); (iv) The first detection rate of atypical cells in CSF of MC patients in our center was 95.22%, and the morphological characteristics were correlated with the primary foci; (v)Dynamic monitoring showed that the level of TM in CSF was consistent with the changes in the proportion of atypical cells in CSF, which could suggest fluctuations in the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this study, it is clear that the clinical characteristics of MC patients and the CSF indicators have specific distribution patterns, and the combined analysis of CSF biochemical indicators, TMr levels and cytomorphology can provide a key basis for the diagnosis of MC, the indication of primary foci and the monitoring of the disease, and the large-scale single-center data provide a reliable support for its clinical application.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1594662","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:22Z","timestamp":1759983742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and analysis of cerebrospinal fluid biochemical, tumor markers and cytologic indices in 209 patients with meningeal carcinomatosis: a cross-sectional study"],"prefix":"10.3389","volume":"15","author":[{"given":"Shaoqiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11864-020-00759-3","article-title":"Leptomeningeal metastases in non-small cell lung cancer: optimal systemic management in NSCLC with and without driver mutations","volume":"21","author":"Alexander","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04471-8","article-title":"Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases","volume":"165","author":"Bai","year":"2023","journal-title":"J Neurooncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000001079","article-title":"Liquid biopsy in brain tumors: moving on, slowly","volume":"36","author":"Berzero","year":"2024","journal-title":"Curr Opin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fac738","article-title":"Leptomeningeal metastases in the MRI era","volume":"76","author":"Chamberlain","year":"2011","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14866","article-title":"Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases","volume":"14","author":"Chiang","year":"2023","journal-title":"Thorac Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/107327481702400118","article-title":"Cerebrospinal fluid dissemination and neoplastic meningitis in primary brain tumors","volume":"24","author":"Chowdhary","year":"2017","journal-title":"Cancer Control"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1076310","article-title":"The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis","volume":"14","author":"Di","year":"2023","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-017-0057-2","article-title":"Cerebrospinal fluid abnormalities in meningeosis neoplastica: a retrospective 12-year analysis","volume":"14","author":"Djukic","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00357.10.1200\/J","article-title":"Management of brain metastases in non-small-cell lung cancer","volume":"15","author":"Ernani","year":"2019","journal-title":"J Oncol Pract"},{"key":"B11","article-title":"Association of cerebrospinal fluid biomarkers with submental and cerebral hemorrhage: a case-control study","volume":"29","author":"Fang","year":"2023","journal-title":"Altern Ther Health Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212121","article-title":"The anatomic basis of leptomeningeal metastasis","volume":"221","author":"Freret","year":"2024","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.12354\/j.issn.1000-8179.2022.20211201","article-title":"Interpretation of Chinese expert consensus on multidisciplinary team diagnosis and treatment of lung cancer (2020 version)","volume":"49","author":"Fu","year":"2022","journal-title":"Chin J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12885-019-5348-3.10.1186\/s12885-019-53","article-title":"Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases","volume":"19","author":"Ge","year":"2019","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-02928-7.10.1007\/s00234-022-","article-title":"MRI sequences and interslice gap influence leptomeningeal metastasis detection in children with brain tumors","volume":"64","author":"Harreld","year":"2022","journal-title":"Neuroradiology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-023-05687-3","article-title":"Metastatic meningioma: a case series and systematic review","volume":"165","author":"Himic","year":"2023","journal-title":"Acta Neurochir (Wien)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13122","DOI":"10.15252\/emmm.202013122.10.15252\/emmm.20","article-title":"Mechanisms of small cell lung cancer metastasis","volume":"13","author":"Ko","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520987946","article-title":"Cerebrospinal fluid tumor markers predict treatment response in a patient with carcinomatous meningitis","volume":"49","author":"Lin","year":"2021","journal-title":"J Int Med Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04520-2","article-title":"Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer","volume":"165","author":"Miao","year":"2023","journal-title":"J Neurooncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/tbj\/5438600","article-title":"Development of a prognostic score in patients with advanced breast cancer treated for meningeal carcinomatosis","volume":"2025","author":"Narjoux","year":"2025","journal-title":"Breast J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30060442","article-title":"Leptomeningeal metastasis: a review of the pathophysiology, diagnostic methodology, and therapeutic landscape","volume":"30","author":"Nguyen","year":"2023","journal-title":"Curr Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025367","article-title":"A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients","volume":"100","author":"Ogawa","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00195-8","article-title":"Overcoming therapy resistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2016.59.6.570","article-title":"Retrospective analysis of cerebrospinal fluid profiles in 228 patients with leptomeningeal carcinomatosis: differences according to the sampling site, symptoms, and systemic factors","volume":"59","author":"Shim","year":"2016","journal-title":"J Korean Neurosurg Soc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.3390\/cells8101195","article-title":"New frontiers in diagnosis and therapy of circulating tumor markers in cerebrospinal fluid in vitro and in vivo","volume":"8","author":"Sindeeva","year":"2019","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411443","article-title":"Leptomeningeal metastases in melanoma patients: an update on and future perspectives for diagnosis and treatment","volume":"24","author":"Steininger","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.theriogenology.2024.01.016","article-title":"Advancing canine mammary tumor diagnostics: unraveling the diagnostic potential of cytokeratin 19 through droplet digital PCR analysis","volume":"217","author":"Tanvetthayanont","year":"2024","journal-title":"Theriogenology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116706","article-title":"Leptomeningeal metastasis from solid tumors","volume":"411","author":"Thakkar","year":"2020","journal-title":"J Neurol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2434","article-title":"Dynamic mutational landscape of cerebrospinal fluid circulating tumor DNA and predictors of survival after proton craniospinal irradiation for leptomeningeal metastases","volume":"29","author":"Wijetunga","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2018.11.003","article-title":"Baseline serum\/cerebrospinal fluid ratio of carcinoembryonic antigen and carbohydrate antigen series biomarkers in non-neoplastic diseases: a cross-sectional study on 224 patients","volume":"63","author":"Zhang","year":"2019","journal-title":"Clin Biochem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2467870","article-title":"Diagnostic value of CYFRA 21\u20131 in the cerebrospinal fluid for leptomeningeal metastasis","volume":"2017","author":"Zhang","year":"2017","journal-title":"Dis Markers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1594662\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:22:25Z","timestamp":1759983745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1594662\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":35,"alternative-id":["10.3389\/fonc.2025.1594662"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1594662","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"article-number":"1594662"}}